Focus on Phase 2 FSMA Implementation

Slides:



Advertisements
Similar presentations
Industry's Role in Promoting Best Practices A Collaborative Approach to Food Safety Global Food Safety Policy Forum Washington DC September 16, 2011.
Advertisements

Moving Forward with Safety Management Systems December 9, 2014 Standing Committee on Public Transportation Winter Meeting American Association of State.
Getting started with the Program Standards David Lawrence EHS III, Fairfax County Health Department Paul Stromp RS/REHS, Lake County General Health District.
Reorganization of APHIS Veterinary Services U.S. Department of Agriculture Animal and Plant Health Inspection Service Veterinary Services November 2013.
Import Controls Phase 2 Workgroup 1.
California Child Welfare Co-Investment Partnership Children’s Conference Monterey, California May 29, 2008.
Intentional Adulteration Phase 2 Workgroup 1.
1 Proposed Rule to Protect Food Against Intentional Adulteration
FSMA Implementation Where We’ve Been, Where We’re Going AND MFRPS March 10, 2015 Roberta F. Wagner, MS Deputy Director for Regulatory Affairs FDA/Center.
Introduction to Regulation
FSMA: Where We’ve Been and Where We’re Going Supplemental Notices of Proposed Rulemaking Public Meeting November 13, 2014 Roberta F. Wagner, B.S., M.S.
Produce Safety Rule Phase 2 Workgroup 1.
Focus on Prevention FDA Food Safety Modernization Act.
1 Webinar on: Establishing a Fully Integrated National Food Safety System with Strengthened Inspection, Laboratory and Response Capacity Sponsored by Partnership.
Education and Technical Assistance Focus on Preventive Controls for Food for Animals U.S. Food and Drug Administration.
Proposed Rule to Protect Food Against Intentional Adulteration 1.
Applying the Federal Cabinet Directive on Streamlining Regulation Regulatory Craft in Nova Scotia Conference 2007 Halifax, Nova Scotia November 20, 2007.
Preventive Controls Phase 2 Workgroup 1.
FDA’s Perspective Continued - Where We Are ?. GMP Task Groups.
21 CFR Part 11 A Food Industry Perspective FDA Public Meeting June 11, 2004 Sia Economides Center Director Center for Development of Research Policy and.
Competency Models Impact on Talent Management
Proposed Rule for Sanitary Transportation of Human and Animal Food
Regulatory Update Ellen Leinfuss SVP, Life Sciences.
Outcomes of Public Health
Multnomah County Health Department ►Essential Services ►FDA Food Standards ►PACE Tools for Food Program Excellence Lila Wickham March 17, 2004 ♣
1 Module 4: Designing Performance Indicators for Environmental Compliance and Enforcement Programs.
ISM Workshop 1 Independent Oversight Perspectives Michael A. Kilpatrick Deputy Director Office of Security and Safety Performance Assurance.
Enhanced Partnerships: Vital to Success Elizabeth M. Calvey, Ph.D. Liaison and Partnership Team Center for Food Safety and Applied Nutrition September.
Ajaz S. Hussain, Ph.D. Deputy Director Office of Pharmaceutical Science, CDER, FDA ACPS Subcommittee on Manufacturing Science: Identification and Prioritization.
National Center for Emerging and Zoonotic Infectious Diseases Centers for Disease Control June 14, 2011 : The Food Safety Modernization Act: Implications.
1 Stakeholder Consultation Mine Safety and Health Administration (MSHA) Department of Labor (DOL) DRAFT Strategic Plan FY Draft: March 17, 2010.
1 Areas of Current Study and FDA’s Strategic Direction Relative to Retail Food Safety.
2015 Safety Action Plan & Regulatory Strategy California Public Utilities Commission January 29, 2015.
1 The Federal Shared Youth Vision Partnership A Federal Partnership between the Corporation for National community Service;
FDA’s Perspective on the “Pharmaceutical cGMPs for the 21st Century” Initiative David J. Horowitz, Esq. Director, CDER/FDA, Office of Compliance Advisory.
Final Rule for Preventive Controls for Human Food September 16, THE FUTURE IS NOW 1.
August, 2013 Grants Circular Reform Update Office of Management and Budget For more information visit
1 U.S. Food and Drug Administration International Programs Melinda K. Plaisier Assistant Commissioner for International Programs U.S. Food and Drug Administration.
NAS/IOM Review of Rare Diseases Research and Orphan Products Development - USA Timothy Cote, M.D., MPH Director, Office of Orphan Products Development.
Compliance Promotion Formalizing an Approach to Support Stakeholder Compliance.
DEVELOPMENT COOPERATION FRAMEWORK Presentation by Ministry of Finance 10 December 2013.
Dr. Shane Renwick, DVM, MSc, A/Director, Animal Health Science Division, Canadian Food Inspection Agency CAHLN, UCVM June 8, 2010 Foresight for Canadian.
Validated Self Evaluation of Alcohol and Drug Partnerships Evidencing Implementation: The Quality Principles – Care Inspectorate/The Scottish Government.
Competency-Development Project 08-October MDIC 2 What is the Competency-Development Project? ‏ Purpose: The purpose of this project is to improve.
Progress in FDA’s Drug Product Quality Initiative Janet Woodcock, M.D. November 13, 2003.
& Food Safety Modernization Act Update North American Agricultural Marketing Officials July 15,
Research in the Office of Vaccines Research and Review: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation and Research.
Overview FDA Food Safety Modernization Act Section 104
Research in the Office of Cellular, Tissue and Gene Therapies: Vision and Overview Jesse Goodman, M.D., M.P.H. Director, Center for Biologics Evaluation.
Title Page Quality Mo Samimi, Ph.D. CMQ/OE Presented at the ASQ Biomedical Division Northern California Discussion Group. May 2011.
1 Prevention of corruption in the private sector: the view from the Anti-Fraud Office of Catalonia Reducing corruption: focusing on private sector corruption.
FDA Preventive Control Regulation Ernest Julian, Ph.D., Chief Office of Food Protection RI Department of Health AFDO 2014.
FSMA Communications and Engagement for International Stakeholders March 21, 2016 Julie Moss, PhD, RD Deputy Director, International Affairs Staff, Center.
1 Introducing the ARC: The New Performance Appraisal Tool for RCs and UNCTs March 2016.
Fostering Antimicrobial Stewardship in Animals: Overview of FDA Activities William Flynn, DVM, MS Deputy Director for Science Policy Center for Veterinary.
The Benefits of VICH to VICH Member Countries and Regions DONALD A. PRATER, DVM Director, U.S. FDA Europe Office Office of International Programs Office.
Advancing Public Health Kaye Bender, RN, PhD, FAAN, President and CEO Public Health Accreditation Board National Public Health Performance Standards Training.
Center for Food Safety and Applied Nutrition Systems Recognition Import System Public Meeting March 21, 2016 Caroline Smith DeWaal International Food Safety.
Safety Management Systems Session Four Safety Promotion APTA Webinar June 9, 2016.
Import Safety Phase 2 Workgroup 1.
Center for Food Safety & Applied Nutrition: Update
FSMA Implementation Jennifer Thomas
An update from CQC Debbie Ivanova DCI South and London Regions 1 1.
CDRH 2010 Strategic Priorities
American Society for Quality Region 5 Quality Conference
Regulating new care models
FSMA: All on the Same Page
Statistics Governance and Quality Assurance: the Experience of FAO
MFRPS in an Integrated Food Safety System
System Safety Regulation
Presentation transcript:

Focus on Phase 2 FSMA Implementation

2 Topics Guiding FSMA Implementation −Program Alignment Initiative −FSMA Operational Strategy FSMA Implementation in Phases Focus on FSMA Phase 2

Collaboration within FDA’s Food Program Office of the Commissioner Acting Commissioner of Food and Drugs Stephen Ostroff, M.D. Directorate of Foods and Veterinary Medicine Deputy Commissioner Michael Taylor, J.D. Center for Food Safety and Applied Nutrition Director Susan Mayne, Ph.D. Center for Veterinary Medicine Director Bernadette Dunham, D.V.M., Ph.D. Directorate of Global Regulatory Operations and Policy Deputy Commissioner Howard Sklamberg, J.D. Office of Regulatory Affairs Associate Commissioner Melinda Plaisier Office of International Programs Associate Commissioner Mary Lou Valdez

Program Alignment Program Alignment Initiative Announced in February 2014 Memo by Commissioner −Vertically integrated, commodity-based programs −Specialization of inspection/compliance staff, regulatory labs −Clear, current, consistently applied policy −Roles, responsibilities, streamlined decision-making −Risk-based allocation of program resources −Agreed-upon performance/public health metrics Result: Successful FSMA Implementation 4

FSMA Operational Strategy Foundation for Developing and Implementing FSMA Standards −Regulations, guidance, protocols Captures in Broad, High-Level Terms Our Current Thinking on Strategy and Guiding Principles for Implementation Made public May 2014 −View at 5

FSMA Implementation as a Continuum Phase 1: Set Standards −Regulations, guidance, policy Phase 2: Planning/Implementation −Design strategies and begin implementation to gain/maintain industry compliance with FSMA rules Phase 3: Implementation, Monitor, Evaluate, Refresh 6

Transition to Phase 2: Planning/Implementation Phase 1 Teams Continue Rulemaking, Guidance and Policy Work until Completed Concurrently, Phase 2 Structure Established/Work Initiated −Design strategies/frameworks and develop operational plans for gaining and maintaining industry compliance with the foundational FSMA rules 7

Phase 2: Operations and Policy Working Together 8

FDA Strategic Program Planning Focus on Steps Steps 9

Phase 2: Workgroup Charge Multi-Year Plan Industry Education, Outreach, Technical Assistance Training for Regulators Inspections, Compliance and Enforcement Data Collection, Analysis, Updated Information Technology (IT) Performance Goals and Metrics 10

12 Phase 2 Guiding Principles FDA Will Speak With One Voice Inspection, Compliance Functions Specialized Investigators and Subject Matter Experts Work Together to Drive Correction of Problems Invest in Regulator Training to Promote Consistent Inspections, Decision Making

13 Phase 2 Guiding Principles Robust Data Integration, Analysis and Information Sharing Work Closely With Government Counterparts and Other Food Safety System Stakeholders Public Health Metrics

14 Phase 2 Guiding Principles Education Before Regulation Facilitate Industry Implementation of Modern, Preventive Practices Through: −Commodity and sector-specific guidance −Education, outreach and technical assistance −Regulatory incentives for compliance

15 Phase 2 Guiding Principles Approach to Operational Activities Improved Risk-Based Work Planning Through Targeted Data Collection and More Timely Data Analysis and Program Evaluation Targeted, Risk-Based Inspection models Range of Inspection, Sampling, Testing, Data Collection Activities

16 Stakeholder Engagement Transparency Remains a Priority Next Phase: Inclusive/Coalition Approach −Engage FDA employees, key partners, the public to determine ways to implement provisions before rules become final Future: Partnerships/Collaboration Key −Establish mechanisms through partnerships and collaboration to foster industry understanding of final rules/guidance and to encourage firms to comply and initiate any corrections on their own

Web site: Subscription feature available Send questions to Public Information Available 17

18 Thank You For Your Attention!